Fresenius Medical Care AG Overview
Pro stress-test →Fresenius Medical Care is the world's leading provider of products and services for individuals with renal disease. The company treats approximately 300,000 patients across nearly 3,700 clinics worldwide and accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. The company operates through a dual-segment model combining clinical dialysis services with medical technology manufacturing.
Strategic Profile
Pro stress-test →The company reported strong organic revenue growth of 10% in Q3 2025, with operating income growth accelerating to 28% and operating income margin expanding to 11.7%. The FME25+ transformation program is delivering sustainable cost savings, with EUR 174 million delivered in the first nine months of 2025 toward a full-year target of EUR 180 million, with cumulative savings expected to reach EUR 1,050 million by year-end 2027. The company has committed to returning excess capital to shareholders through an initial EUR 1 billion share buyback program commenced in August.
Competitive Landscape
Pro stress-test →Fresenius Medical Care is the largest dialysis provider globally and accounts for approximately 35% of the global dialysis products market. The competitive landscape includes other major dialysis providers and medical device manufacturers. Services account for about three-fourths of sales, while medical technology products enabling dialysis treatments generate the balance.
Industry Context
Fresenius Medical Care AG operates in Healthcare Providers and Services - Dialysis and Renal Care.
Key facts
Founded: 1996 · Headquarters: Bad Homburg, Germany · Employees: 112,035 · Revenue: $21.95B · Market cap: $13.15B